Opioid Agonist Therapy (OAT) associated with lower risk of multiple causes of death for people with opioid dependence
Opioid Agonist Therapy (OAT) associated with lower risk of multiple causes of death for people with opioid dependence
A new global review has found that receiving Opioid Agonist Therapy (OAT) is associated with lower risk of multiple causes of death among people with opioid dependence.
The review found that people with opioid dependence were less likely to experience overdose-related, suicide, alcohol-related, cancer, and cardiovascular-related mortality while receiving OAT.
Researchers from the National Drug and Alcohol Research Centre (NDARC) at UNSW Sydney, University of Bristol and several other global institutions reviewed the relationship between OAT and mortality across type of drug, setting and participant groups from over 700,000 participants, which is six times the number of any other previous review. (National Drug and Alcohol Research Centre (NDARC), Australien, 03.06.2021)
https://ndarc.med.unsw.edu.au/news/opioid-agonist-therapy-oat-associated-lower-risk-multiple-causes-death-people-opioid-dependence